Generic name Mifepristone, trade name in France and the U.K. Mifegyne.
2.
“RU 486 as an Antiprogesterone Steroid: From Receptor to Contragestion and Beyond,”J.A.M.A., 262, (1989): 1808–1814; special article on the occasion of the Lasker Award for clinical research.
3.
“Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor,”Science, 245, (1989): 1351–1356.
4.
OdileJacob, Paris, 1990, translated and adapted for an English-speaking readership: The Abortion Pill, New York(Simon & Schuster), 1991.
5.
Progesterone is a steroid hormone indispensable for the beginning and the continuation of pregnancy.
6.
Three containing each 200 mg of RU 486 and taken together.
7.
Time of optimal antiprogesterone activity.
8.
Prostaglandins are local hormones which are naturally involved in contractions of the uterus during delivery and abortion and physiologically help expulsion.
9.
95 percent or more complete successes.
10.
BygdemanM.Dr.
11.
A PG-E2 derivative.
12.
AubényE. and BaulieuE.E., “Activité contragestive de l'association au RU 486 d'une prostaglandine active par voie orale, ”CR Acadm. Sci. Paris, 312, (1991): 539–545.
13.
NormanJ.E.ThongK.J.BairdD.T., “Uterine Contractility and Induction of Abortion in Early Pregnancy by Misoprostol and Mifepristone, ”338 The Lancet1233–1236 (1991).
14.
It was proposed to decrease RU 486 dosage when associated with Sulprostone or Gemeprost; however these prostaglandins were given at probably larger than adequate doses, and the data presented so far are irrelevant to the use of Misoprostol.
15.
Registration on July 1st, 1991.
16.
New York.
17.
Signed in 1982, and remaining valid.
18.
Frankfurt.
19.
HRPI.
20.
CookRebecca, International Protection of Women's Reproductive Rights 24, New York University, 401–483 (1992).
21.
There is no predictable fetal abnormality, but there is no reason to take an additional risk.
22.
Registration just obtained in France.
23.
Objective: A baby in better health.
24.
With Cushing syndromes, meningiomas.
25.
RadestadAChristensenN. J.StrombergL., “Induced Cervical Ripening with Mifepristone in First Trimester Pregancy, ”Contraception38 (1988); BygdemanM.SwahnM.L.JohannissonE., “The Effect of RU 486 Administered During the Proliferative and Secretory Phase of the Bleeding Pattern, Hormonal Parameters and the Endometrium, ”Human Reproduction3 (1988): 915–21.
26.
See supra note 2.
27.
We should be free to have different opinions about this, just as we do about the future of a human being after death.
